Brief: Adicet Bio Q3 Basic EPS USD -0.34
06/11/2024 21:00
Nov 06 (Reuters) - Adicet Bio Q3 net income USD -30.478 million. * Q3 operating income USD -33.153 million * Q3 operating expenses USD 33.153 million
Recent news on ADICET Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Adicet Bio Announces Positive Safety And Efficacy Data From Prula-Cel (Formerly Adi-001) Study In Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis
Brief: Adicet Bio Announces FDA Clearance Of Ind Application For Adi-212
Adicet Bio, Inc. Reports Results For The Quarter Ended June 30: Earnings Summary